Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

The impact of intestinal transplantation on quality of life.

Ambrose T, Holdaway L, Smith A, Howe H, Vokes L, Vrakas G, Reddy S, Giele H, Travis SPL, Friend PJ, Allan PJ.

Clin Nutr. 2019 Aug 31. pii: S0261-5614(19)33035-3. doi: 10.1016/j.clnu.2019.08.023. [Epub ahead of print]

PMID:
31522787
2.

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

Panaccione R, Colombel JF, Travis SPL, Bossuyt P, Baert F, Vaňásek T, Danalıoğlu A, Novacek G, Armuzzi A, Reinisch W, Johnson S, Buessing M, Neimark E, Petersson J, Lee WJ, D'Haens GR.

Gut. 2019 Jul 8. pii: gutjnl-2019-318256. doi: 10.1136/gutjnl-2019-318256. [Epub ahead of print]

3.

Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis.

Vleugels JLA, Rutter MD, Ragunath K, Rees CJ, Ponsioen CY, Lahiff C, Ket SN, Wanders LK, Samuel S, Butt F, Kuiper T, Travis SPL, D'Haens G, Wang LM, van Eeden S, East JE, Dekker E.

J Crohns Colitis. 2019 May 24. pii: jjz074. doi: 10.1093/ecco-jcc/jjz074. [Epub ahead of print] No abstract available.

PMID:
31125049
4.

Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.

Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, Schoeman S, Lim A, Bartholomeusz FD, Travis SPL, Andrews JM.

Inflamm Bowel Dis. 2019 May 4;25(6):e62-e63. doi: 10.1093/ibd/izy338. No abstract available.

PMID:
30380064
5.

Polyp-adjacent biopsies no longer required in inflammatory bowel disease.

Lahiff C, Wang LM, Travis SPL, East JE.

Gastrointest Endosc. 2018 Oct;88(4):782-783. doi: 10.1016/j.gie.2018.05.005. No abstract available.

PMID:
30217249
6.

Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.

Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, Schoeman S, Lim A, Bartholomeusz FD, Travis SPL, Andrews JM.

Inflamm Bowel Dis. 2019 Feb 21;25(3):592-600. doi: 10.1093/ibd/izy278.

PMID:
30215805
7.

Diagnostic Accuracy of Endoscopic Trimodal Imaging and Chromoendoscopy for Lesion Characterization in Ulcerative Colitis.

Vleugels JLA, Rutter MD, Ragunath K, Rees CJ, Ponsioen CY, Lahiff C, Ket SN, Wanders LK, Samuel S, Butt F, Kuiper T, Travis SPL, D'Haens G, Wang LM, van Eeden S, East JE, Dekker E.

J Crohns Colitis. 2018 Nov 28;12(12):1438-1447. doi: 10.1093/ecco-jcc/jjy129.

PMID:
30202856
8.

Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia.

Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, Schoeman SN, Lim A, Bartholomeusz FD, Travis SPL, Andrews JM.

Nutrients. 2018 Sep 1;10(9). pii: E1192. doi: 10.3390/nu10091192.

9.

Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas.

Das B, Ghosh TS, Kedia S, Rampal R, Saxena S, Bag S, Mitra R, Dayal M, Mehta O, Surendranath A, Travis SPL, Tripathi P, Nair GB, Ahuja V.

Sci Rep. 2018 Jul 4;8(1):10104. doi: 10.1038/s41598-018-28550-3.

10.

Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.

Kedia S, Jain S, Goyal S, Bopanna S, Yadav DP, Sachdev V, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V.

Dig Dis Sci. 2018 Oct;63(10):2747-2753. doi: 10.1007/s10620-018-5157-6. Epub 2018 Jun 8.

PMID:
29948556
11.

Consequences of Identifying XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease.

Quaranta M, Wilson R, Gonçalves Serra E, Pandey S, Schwerd T, Gilmour K, Klenerman P, Powrie F, Keshav S, Travis SPL, Anderson CA, Uhlig HH.

Gastroenterology. 2018 Jul;155(1):231-234. doi: 10.1053/j.gastro.2018.03.069. Epub 2018 Jun 9. No abstract available.

PMID:
29894681
12.

Correlation Between Endoscopic and Histological Activity in Ulcerative Colitis Using Validated Indices.

Irani NR, Wang LM, Collins GS, Keshav S, Travis SPL.

J Crohns Colitis. 2018 Nov 9;12(10):1151-1157. doi: 10.1093/ecco-jcc/jjy081.

PMID:
29893824
13.

Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials.

Feagan BG, Bhayat F, Khalid M, Blake A, Travis SPL.

J Crohns Colitis. 2018 Jul 30;12(8):905-919. doi: 10.1093/ecco-jcc/jjy047.

14.

Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes from the European Society for Blood and Marrow Transplantation.

Brierley CK, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J, Onida F, Cassinotti A, Satsangi J, Kazmi M, López-Sanromán A, Schmidt C, Farge D, Travis SPL, Hawkey CJ, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP).

J Crohns Colitis. 2018 May 18. doi: 10.1093/ecco-jcc/jjy069. [Epub ahead of print]

15.

Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis?

Fairhurst NG, Travis SPL.

Intest Res. 2018 Apr;16(2):209-215. doi: 10.5217/ir.2018.16.2.209. Epub 2018 Apr 30. Review.

16.

Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.

Vleugels JLA, Rutter MD, Ragunath K, Rees CJ, Ponsioen CY, Lahiff C, Ket SN, Wanders LK, Samuel S, Butt F, Kuiper T, Travis SPL, D'Haens G, Wang LM, van Eeden S, East JE, Dekker E.

Lancet Gastroenterol Hepatol. 2018 May;3(5):305-316. doi: 10.1016/S2468-1253(18)30055-4. Epub 2018 Mar 20.

PMID:
29567006
17.

Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study.

Jain S, Kedia S, Bopanna S, Yadav DP, Goyal S, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V.

Intest Res. 2018 Jan;16(1):69-74. doi: 10.5217/ir.2018.16.1.69. Epub 2018 Jan 18.

18.

Diagnostic Yield of Dysplasia in Polyp-adjacent Biopsies for Patients with Inflammatory Bowel Disease: A Cross-sectional Study.

Lahiff C, Mun Wang L, Travis SPL, East JE.

J Crohns Colitis. 2018 May 25;12(6):670-676. doi: 10.1093/ecco-jcc/jjy007.

PMID:
29385427
19.

NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.

Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier JB, Jung J, Mondal K, Parkes M, Mathew CG, Fiedler K, McCarthy DJ; WGS500 Consortium; Oxford IBD cohort study investigators; COLORS in IBD group investigators; UK IBD Genetics Consortium, Sullivan PB, Rodrigues A, Travis SPL, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J; INTERVAL Study, Russell RK, Wilson DC, Kelsen JR, Cornall R, Denson LA, Kugathasan S, Knaus UG, Serra EG, Anderson CA, Duerr RH, McGovern DP, Cho J, Powrie F, Li VS, Muise AM, Uhlig HH.

Mucosal Immunol. 2018 Mar;11(2):562-574. doi: 10.1038/mi.2017.74. Epub 2017 Nov 1.

20.

Faecal Calprotectin and UCEIS Predict Short-term Outcomes in Acute Severe Colitis: Prospective Cohort Study.

Jain S, Kedia S, Bopanna S, Sachdev V, Sahni P, Dash NR, Pal S, Vishnubhatla S, Makharia G, Travis SPL, Ahuja V.

J Crohns Colitis. 2017 Oct 27;11(11):1309-1316. doi: 10.1093/ecco-jcc/jjx084.

PMID:
29088461

Supplemental Content

Loading ...
Support Center